KRT40 Antibody

What is KRT40 and what cellular functions does it serve?

KRT40, also known as Keratin 40, is a type I cytoskeletal keratin protein with a molecular weight of approximately 48 kDa and consists of 431 amino acids . It belongs to the keratin family and is also referred to by several synonyms including CK-40, K40, KA36, Cytokeratin-40, and Type I hair keratin Ka36 . KRT40 is encoded by the KRT40 gene (Gene ID: 125115) in humans . This protein is primarily expressed in epithelial tissues and, like other keratins, contributes to the structural integrity of cells. Keratins typically function as components of the cytoskeleton and play critical roles in cell signaling, differentiation, and stress responses. KRT40 specifically belongs to the type I keratin family, which forms heterodimers with type II keratins to create intermediate filaments within epithelial cells.

What sample types can be effectively analyzed with KRT40 antibodies?

KRT40 antibodies can be used to analyze various biological samples depending on the experimental design and antibody specifications. Based on the available product information, compatible sample types include:

• Serum and plasma (validated specifically for citrated/EDTA plasma)

• Cell culture supernatants

• Cell lysates (particularly from epithelial cell lines like A431)

• Tissue sections for immunohistochemistry applications

• Fixed cells for immunofluorescence studies

When working with these samples, it's essential to follow the manufacturer's recommended protocols for sample preparation to ensure optimal antibody performance. Many antibodies require specific buffers and processing conditions that can significantly impact detection sensitivity and specificity.

What are the primary applications for KRT40 antibodies in research?

KRT40 antibodies support multiple experimental approaches in research settings. The primary validated applications include:

These applications enable researchers to investigate KRT40 expression patterns, protein-protein interactions, and potential roles in cellular processes or disease states. The choice of application should align with specific research questions and available sample types.

How can I optimize Western blot protocols for reliable KRT40 detection?

Optimizing Western blot protocols for KRT40 detection requires attention to several critical factors:

• Sample preparation: Ensure complete lysis using appropriate buffers containing protease inhibitors. For keratins, which can be resistant to solubilization, consider using stronger lysis buffers containing urea or SDS.

• Protein loading: The recommended loading amount varies by sample type and antibody sensitivity. Start with 20-30 μg of total protein and adjust based on initial results.

• Antibody selection and dilution: For KRT40, a dilution range of 1:200-1:1000 is typically recommended for Western blot applications . Begin with a mid-range dilution (1:500) and optimize as needed.

• Blocking conditions: 5% non-fat dry milk or BSA in TBST is typically effective, but some KRT40 antibodies may perform better with specific blocking reagents.

• Incubation times and temperatures: Primary antibody incubation can be performed overnight at 4°C for maximum sensitivity or for 1-2 hours at room temperature for faster results.

• Detection system: Choose an appropriate secondary antibody and detection method based on your sensitivity requirements. For low abundance expression, consider using enhanced chemiluminescence or fluorescent detection systems.

• Positive controls: Include A431 cells, which have been validated for KRT40 expression, as a positive control in your experiments .

These optimizations should be systematically implemented and documented to establish a reproducible protocol for KRT40 detection.

What are the key differences between polyclonal and monoclonal antibodies for KRT40 detection?

The choice between polyclonal and monoclonal antibodies for KRT40 detection depends on your specific research needs:

Polyclonal Antibodies:

• Recognize multiple epitopes on the KRT40 protein, potentially increasing detection sensitivity

• Often show greater tolerance to protein denaturation or fixation

• Typically work well across multiple applications

• Examples include rabbit polyclonal antibodies like the one from Proteintech (25398-1-AP)

• May show batch-to-batch variation and potential for cross-reactivity

Monoclonal Antibodies:

• Recognize a single epitope, providing higher specificity

• Show minimal batch-to-batch variation

• May be more sensitive to conformational changes in the target

• Available in various formats, including recombinant antibodies like the mouse anti-KRT40 recombinant antibody (clone AE13)

• Often more suitable for standardized assays requiring consistent results

For initial characterization and detection across multiple applications, polyclonal antibodies often provide greater flexibility. For highly specific detection or quantitative assays requiring reproducibility across experiments, monoclonal antibodies may be preferable.

How should I validate the specificity of KRT40 antibodies in my experimental system?

Validating KRT40 antibody specificity is crucial for ensuring reliable experimental results. A comprehensive validation approach should include:

• Positive and negative controls:

  • Use cell lines with known KRT40 expression (e.g., A431 cells) as positive controls

  • Include cell lines or tissues not expected to express KRT40 as negative controls

  • Consider using knockout/knockdown models when available

• Western blot validation:

  • Verify a single band at the expected molecular weight (~48 kDa for KRT40)

  • Assess cross-reactivity with other keratin family members

  • Test pre-adsorption of the antibody with recombinant KRT40 protein

• Peptide competition assay:

  • Pre-incubate the antibody with the immunogen peptide used for antibody generation

  • Compare results with and without peptide competition

  • Signal reduction in the presence of the peptide indicates specificity

• Cross-application validation:

  • Confirm consistent results across multiple detection methods (e.g., IHC, IF, WB)

  • Compare results from multiple antibodies targeting different KRT40 epitopes

• Recombinant protein standards:

  • Use purified recombinant KRT40 proteins as standards in quantitative assays

  • Establish concentration ranges for standard curves

Thorough validation not only ensures experimental reliability but also helps identify optimal conditions for specific applications and sample types.

What experimental approaches can resolve inconsistent KRT40 antibody results across different conditions?

Inconsistent KRT40 antibody results can stem from multiple sources. Advanced troubleshooting approaches include:

• Epitope mapping analysis:

  • Different antibodies target distinct epitopes that may be affected differently by experimental conditions

  • For example, the immunogen sequence "CSPCSTTCTSSNTCEPCSAYVICTVENCCL" used in some KRT40 antibodies may be sensitive to specific fixation or denaturation methods

  • Map the exact epitope recognized by your antibody and assess its accessibility under various conditions

• Post-translational modification interference:

  • Investigate whether phosphorylation, glycosylation, or other modifications affect epitope recognition

  • Use phosphatase or glycosidase treatments to assess if modifications influence antibody binding

• Protein conformational analysis:

  • Native vs. denatured conditions may significantly impact KRT40 detection

  • Compare results under native conditions (e.g., non-denaturing gels) with standard denaturing conditions

  • Consider using cross-linking approaches to assess KRT40 in its native conformational state

• Sample preparation matrix effects:

  • Systematically compare different lysis buffers (RIPA, urea-based, Laemmli) to identify optimal extraction conditions

  • Assess the impact of protease inhibitor cocktails and phosphatase inhibitors

  • Evaluate the effects of sample heating time and temperature on epitope accessibility

• Antibody batch characterization:

  • Perform side-by-side testing of different antibody lots

  • Create internal reference standards to normalize across experiments

  • Consider using recombinant antibodies for greater consistency

Implementing these advanced approaches can help identify the sources of variability and establish more reproducible experimental conditions.

How does fixation method affect KRT40 epitope recognition in immunohistochemistry and immunofluorescence studies?

Fixation methods can significantly impact KRT40 detection in microscopy-based studies. Advanced considerations include:

• Chemical crosslinking effects:

  • Formaldehyde-based fixatives (4% PFA, formalin) create protein crosslinks that may mask certain KRT40 epitopes

  • Methanol fixation denatures proteins without crosslinking, potentially exposing different epitopes

  • Glutaraldehyde provides stronger fixation but may cause greater epitope masking

  • For KRT40 IF studies, testing both crosslinking and precipitating fixatives is recommended

• Epitope retrieval optimization:

  • Heat-induced epitope retrieval (HIER) using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) can recover masked epitopes

  • Enzymatic retrieval using proteinase K or trypsin may be effective for certain KRT40 epitopes

  • The optimal retrieval method depends on the specific antibody and the epitope it recognizes

• Fixation time and temperature effects:

  • Short fixation times may preserve epitopes but compromise tissue morphology

  • Extended fixation may better preserve structure but increase epitope masking

  • Cold fixation (4°C) versus room temperature fixation can affect both the rate and extent of fixation

• Dual fixation protocols:

  • Sequential fixation with different fixatives (e.g., methanol followed by PFA) may preserve both structure and epitope accessibility

  • Optimization of dual fixation timing can maximize both morphological preservation and antibody binding

• Post-fixation blocking and permeabilization:

  • For IF applications with KRT40 antibodies (recommended concentration: 0.25-2 μg/mL) , optimization of blocking agents is crucial

  • Permeabilization methods (Triton X-100, saponin, digitonin) can differentially affect cytoskeletal protein accessibility

These considerations should be systematically evaluated when establishing immunohistochemistry or immunofluorescence protocols for KRT40 detection.

What are the key considerations for multiplexing KRT40 detection with other keratin family members?

Simultaneous detection of multiple keratin family members presents specific technical challenges that require advanced planning:

• Antibody species and isotype selection:

  • Choose primary antibodies raised in different host species (e.g., rabbit anti-KRT40 and mouse anti-KRT5)

  • When limited by available species, use different isotypes (IgG1, IgG2a, IgG2b) with isotype-specific secondary antibodies

  • Consider using directly conjugated primary antibodies to avoid species cross-reactivity

• Spectral overlap minimization:

  • For fluorescent multiplexing, select fluorophores with minimal spectral overlap

  • Implement appropriate compensation controls when using flow cytometry

  • Consider sequential detection methods for closely related fluorophores

• Cross-reactivity assessment:

  • Pre-test each antibody individually before multiplexing

  • Perform blocking experiments with unlabeled antibodies to prevent shared epitope binding

  • Include controls omitting each primary antibody to confirm specificity of detection

• Sequential staining protocols:

  • For challenging combinations, consider sequential staining with intermediate fixation

  • When using tyramide signal amplification, include peroxidase quenching steps between detections

  • Document the order of staining to account for potential epitope masking

• Quantitative considerations:

  • Establish detection thresholds for each keratin separately before multiplexing

  • Use consistent exposure settings when comparing samples

  • Include single-stained controls for accurate quantification

• Advanced imaging considerations:

  • Implement spectral unmixing for fluorophores with partial overlap

  • Consider super-resolution techniques for distinguishing closely associated keratins

  • Use deconvolution methods to improve signal separation

These approaches enable researchers to reliably detect KRT40 alongside other keratin family members, providing valuable insights into their potential co-expression and interactions.

What controls are essential when using KRT40 ELISA kits for quantitative analysis?

Quantitative analysis using KRT40 ELISA kits requires rigorous controls to ensure reliable results:

• Standard curve optimization:

  • Use the full range of provided standards (typically 0.156-10 ng/mL for KRT40)

  • Perform replicate measurements of each standard

  • Verify linearity within the working range and calculate R² values (should be >0.98)

  • Consider using a 5-parameter logistic fit for improved accuracy at the extremes of the curve

• Sample dilution optimization:

  • Test multiple dilutions of samples to ensure readings fall within the linear range

  • Create dilution series to verify proportional changes in signal with dilution (parallelism)

  • Document matrix effects by comparing dilutions in different buffers

• Quality control samples:

  • Include low, medium, and high concentration QC samples on each plate

  • Calculate inter-assay and intra-assay coefficients of variation (CVs should be <15%)

  • Consider creating an internal reference pool as a long-term control

• Recovery and spike-in controls:

  • Spike known quantities of recombinant KRT40 protein into sample matrix

  • Calculate percent recovery to assess matrix interference

  • Consider using the purified KRT40 protein available from commercial sources

• Cross-reactivity assessment:

  • Test samples containing related keratin family members

  • Verify assay specificity using cellular models with known KRT40 expression patterns

  • Review assay documentation for potential cross-reactants

• Plate layout considerations:

  • Distribute controls across the plate to detect position effects

  • Include blank wells (no primary antibody) to assess non-specific binding

  • Consider running critical samples in duplicate or triplicate

For KRT40 sandwich ELISA kits, which typically employ double antibody systems (capture and detection antibodies) , these controls are essential for ensuring accurate and reproducible quantification across experiments.

What are the recommended approaches for studying KRT40 expression in human tissues?

Studying KRT40 expression in human tissues requires careful consideration of methodological approaches:

• Tissue microarray (TMA) analysis:

  • Enables simultaneous screening of multiple tissue types

  • Facilitates standardized staining conditions across diverse samples

  • Resources like the Human Protein Atlas provide validated IHC images for KRT40 across tissues

• Multiplex in situ hybridization:

  • Combines KRT40 mRNA detection with protein immunodetection

  • Verifies expression at both transcriptional and translational levels

  • Especially valuable for resolving antibody specificity concerns

• Laser capture microdissection:

  • Isolates specific cell populations expressing KRT40

  • Enables region-specific expression analysis

  • Can be combined with RT-qPCR or proteomics for quantitative assessment

• Optimized immunohistochemistry protocols:

  • For KRT40 detection, recommended antibody dilutions range from 1:20 to 1:50

  • Epitope retrieval methods should be systematically optimized

  • Chromogenic (DAB) versus fluorescent detection should be selected based on research goals

• Digital pathology approaches:

  • Enables quantitative analysis of staining intensity and distribution

  • Facilitates co-localization studies with other markers

  • Allows for unbiased assessment of expression patterns

• Single-cell analysis:

  • Provides insights into cellular heterogeneity of KRT40 expression

  • Can be performed using indexed sorting followed by RT-qPCR

  • Single-cell proteomics approaches are emerging for protein-level validation

These approaches can be integrated to provide comprehensive insights into KRT40 expression patterns across normal and pathological human tissues.

How can I design and validate KRT40 knockdown or knockout experiments?

Designing effective KRT40 knockdown or knockout experiments requires careful consideration of several methodological aspects:

• siRNA/shRNA design for knockdown studies:

  • Design multiple siRNA sequences targeting different regions of KRT40 mRNA

  • Avoid sequences with potential off-target effects using algorithms like BLAST

  • Include non-targeting controls and positive controls (targeting housekeeping genes)

  • Verify knockdown efficiency at both mRNA (RT-qPCR) and protein levels (Western blot using validated antibodies)

• CRISPR/Cas9 approach for knockout generation:

  • Design multiple guide RNAs targeting early exons of KRT40

  • Consider using paired guides for generating larger deletions

  • Screen clones using genomic PCR followed by sequencing

  • Validate knockout at the protein level using qualified KRT40 antibodies that recognize distinct epitopes

• Functional validation approaches:

  • Assess phenotypic changes in cellular morphology and cytoskeletal organization

  • Evaluate potential compensatory upregulation of other keratin family members

  • Examine effects on cell migration, adhesion, and response to mechanical stress

  • Test if reintroduction of KRT40 rescues the observed phenotypes

• Controls and alternative approaches:

  • Include rescue experiments with siRNA-resistant KRT40 constructs

  • Use inducible systems (Tet-On/Off) for temporal control of knockdown/knockout

  • Consider domain-specific mutations as alternatives to complete knockout

  • Use multiple cell lines to account for cell type-specific effects

• Validation using complementary techniques:

  • Combine genetic approaches with antibody neutralization experiments

  • Correlate findings with tissue expression data from The Human Protein Atlas

  • Consider using human disease-relevant models when available

These methodological considerations ensure that observed phenotypes can be specifically attributed to alterations in KRT40 expression or function.

What analytical techniques can resolve challenges in detecting low-abundance KRT40 expression?

Detection of low-abundance KRT40 expression presents specific challenges that can be addressed through advanced analytical approaches:

• Signal amplification methods:

  • Tyramide signal amplification (TSA) can increase detection sensitivity by 10-100 fold

  • Proximity ligation assay (PLA) enables single-molecule detection of KRT40 and its interaction partners

  • RNAscope technology can detect low-abundance KRT40 mRNA with cellular resolution

• Enrichment strategies:

  • Cytoskeletal fractionation to concentrate keratin proteins

  • Immunoprecipitation followed by Western blotting (IP-WB)

  • Laser capture microdissection to isolate KRT40-expressing cells

• High-sensitivity detection systems:

  • For Western blot, femto-sensitive chemiluminescent substrates

  • For immunofluorescence, high-quantum yield fluorophores and spectral imaging

  • For ELISA, enzyme-based amplification systems with detection limits in the pg/mL range

• Digital PCR for transcript analysis:

  • Enables absolute quantification of KRT40 mRNA

  • Higher sensitivity than traditional qPCR for low-copy transcripts

  • Less affected by PCR inhibitors in complex samples

• Mass spectrometry approaches:

  • Selected reaction monitoring (SRM) for targeted detection of KRT40 peptides

  • Data-independent acquisition (DIA) for comprehensive profiling

  • Peptide immunocapture followed by mass spectrometry (SISCAPA)

• New-generation antibody formats:

  • Single-chain variable fragments (scFvs) for improved tissue penetration

  • Nanobodies with access to previously inaccessible epitopes

  • Recombinant antibody fragments with engineered affinity

When implementing these techniques, it's essential to maintain appropriate positive and negative controls to distinguish genuine low-level expression from background signal.

What are emerging technologies for studying KRT40 interactions with other cellular components?

Several cutting-edge technologies are advancing our understanding of KRT40's interactions within the cellular context:

• Proximity-based interaction mapping:

  • BioID or TurboID approaches using KRT40 fusion proteins to identify proximal proteins

  • APEX2-based proximity labeling for subcellular interaction mapping

  • Split-protein complementation assays to validate direct interactions

• Live-cell imaging approaches:

  • FRAP (Fluorescence Recovery After Photobleaching) to study KRT40 dynamics

  • FRET-FLIM for measuring nanoscale interactions between KRT40 and binding partners

  • Lattice light-sheet microscopy for 3D visualization of KRT40 filament networks

• Correlation microscopy methods:

  • CLEM (Correlative Light and Electron Microscopy) to bridge ultrastructural and molecular information

  • Super-resolution microscopy (STORM, PALM, SIM) for detailed visualization of KRT40 filament organization

  • Volume EM techniques for comprehensive 3D analysis of cytoskeletal architecture

• Structural biology approaches:

  • Cryo-electron tomography of intact cellular regions containing KRT40

  • Cross-linking mass spectrometry (XL-MS) to map interaction interfaces

  • Integrative structural modeling combining multiple data sources

• Systems biology integration:

  • Network analysis incorporating KRT40 into cytoskeletal interaction maps

  • Multi-omics approaches combining proteomics, transcriptomics, and imaging data

  • Mathematical modeling of keratin filament assembly and dynamics

These emerging technologies provide unprecedented insights into how KRT40 functions within the complex cellular environment and offer new avenues for functional characterization.

How can KRT40 antibodies be effectively used in multiplexed imaging platforms?

Incorporating KRT40 antibodies into multiplexed imaging requires consideration of several advanced technical aspects:

• Cyclic immunofluorescence approaches:

  • Sequential staining, imaging, and signal removal enables detection of dozens of targets

  • Compatible antibody formats for repeated rounds of staining

  • Optimization of epitope preservation across multiple cycles

• Mass cytometry imaging (IMC):

  • Metal-conjugated KRT40 antibodies for highly multiplexed tissue imaging

  • Panel design strategies incorporating KRT40 with other cellular markers

  • Data analysis workflows for segmentation and quantification

• Digital spatial profiling platforms:

  • Integration of KRT40 antibodies into multiplexed panels

  • Spatial resolution considerations for subcellular localization

  • Quantitative analysis of KRT40 expression gradients

• Antibody conjugation strategies:

  • Direct conjugation of KRT40 antibodies with bright, photostable fluorophores

  • DNA-barcoded antibodies for exchange-PAINT super-resolution imaging

  • Optimization of conjugation chemistry to maintain affinity and specificity

• Computational analysis approaches:

  • Machine learning algorithms for automated segmentation of KRT40-positive structures

  • Spatial statistics for quantifying co-localization with other markers

  • 3D reconstruction and rendering techniques for volumetric analysis

These approaches enable researchers to place KRT40 expression within its broader tissue and cellular context, providing insights into its relationships with other cellular components and potential functional roles.